Paul W. Hoelscher
2017
In 2017, Paul W. Hoelscher earned a total compensation of $930.1K as Executive Vice President, Chief Financial Officer at Horizon Pharma, a 3% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $319,110 |
|---|---|
| Salary | $541,667 |
| Other | $69,335 |
| Total | $930,112 |
Hoelscher received $541.7K in salary, accounting for 58% of the total pay in 2017.
Hoelscher also received $319.1K in non-equity incentive plan and $69.3K in other compensation.
Rankings
In 2017, Paul W. Hoelscher's compensation ranked 9,311th out of 14,666 executives tracked by ExecPay. In other words, Hoelscher earned more than 36.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,311 out of 14,666 | 37th |
Division Manufacturing | 3,576 out of 5,770 | 38th |
Major group Chemicals And Allied Products | 1,229 out of 2,074 | 41st |
Industry group Drugs | 988 out of 1,730 | 43rd |
Industry Pharmaceutical Preparations | 776 out of 1,329 | 42nd |
Source: SEC filing on April 2, 2018.
Hoelscher's colleagues
We found six more compensation records of executives who worked with Paul W. Hoelscher at Horizon Pharma in 2017.
2017
Timothy Walbert
Horizon Pharma
Chief Executive Officer
2017
Irina Konstantinovsky
Horizon Pharma
Chief Human Resources Officer
2017
David Happel
Horizon Pharma
Executive Vice President, Commercial Development and Strategy
2017
Barry Moze
Horizon Pharma
Chief Administrative Officer
2017
Robert Carey
Horizon Pharma
Executive Vice President, Chief Business Officer
2017
Vikram Karnani
Horizon Pharma
Executive Vice President, Chief Commercial Officer
News
Horizon Pharma CEO Timothy Walbert's 2021 pay slips 1% to $21M
March 17, 2022
Horizon Pharma CEO Timothy Walbert's 2020 pay jumps 56% to $22M
March 17, 2021
Horizon Pharma CEO Timothy Walbert's 2019 pay slips 17% to $14M
March 18, 2020
Horizon Pharma CEO Timothy Walbert's 2018 pay jumps 617% to $17M
April 8, 2019